Clinical Trials Browser

Phase NA × Terminated × Myasthenia Gravis × Clear all

NCT06965309 2026-02-12

Efficacy and Safety of HN2301 in Refractory Myasthenia Gravis(MG)

Phase NA Terminated

Myasthenia Gravis

NCT00004682 2015-03-25

Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis

Phase NA Terminated

Mental Disorders, Myasthenia Gravis, Neurologic Manifestations, Rare Diseases